KROS logo

Keros Therapeutics (KROS) Depreciation And Amortization

Annual D&A

$1.23 M
+$414.00 K+50.80%

December 31, 2024


Summary


Performance

KROS Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$332.00 K
+$18.00 K+5.73%

December 31, 2024


Summary


Performance

KROS Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$1.23 M
+$85.00 K+7.43%

December 31, 2024


Summary


Performance

KROS TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

KROS Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.8%0.0%0.0%
3 y3 years+225.1%+219.2%+225.1%
5 y5 years+490.9%+462.7%+490.9%

KROS Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+225.1%at high+219.2%at high+225.1%
5 y5-yearat high+490.9%at high+462.7%at high+490.9%
alltimeall timeat high+703.3%at high+637.8%at high+2631.1%

Keros Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$1.23 M(+50.8%)
$332.00 K(+5.7%)
$1.23 M(+7.4%)
Sep 2024
-
$314.00 K(+2.6%)
$1.14 M(+10.0%)
Jun 2024
-
$306.00 K(+10.5%)
$1.04 M(+12.4%)
Mar 2024
-
$277.00 K(+12.1%)
$925.00 K(+13.5%)
Dec 2023
$815.00 K(+20.9%)
$247.00 K(+17.6%)
$815.00 K(+17.3%)
Sep 2023
-
$210.00 K(+9.9%)
$695.00 K(+13.7%)
Jun 2023
-
$191.00 K(+14.4%)
$611.00 K(-16.1%)
Mar 2023
-
$167.00 K(+31.5%)
$728.00 K(+8.0%)
Dec 2022
$674.00 K(+78.3%)
$127.00 K(+0.8%)
$674.00 K(+3.5%)
Sep 2022
-
$126.00 K(-59.1%)
$651.00 K(+3.7%)
Jun 2022
-
$308.00 K(+172.6%)
$628.00 K(+52.8%)
Mar 2022
-
$113.00 K(+8.7%)
$411.00 K(+8.7%)
DateAnnualQuarterlyTTM
Dec 2021
$378.00 K(+36.0%)
$104.00 K(+1.0%)
$378.00 K(+8.3%)
Sep 2021
-
$103.00 K(+13.2%)
$349.00 K(+9.7%)
Jun 2021
-
$91.00 K(+13.8%)
$318.00 K(+7.8%)
Mar 2021
-
$80.00 K(+6.7%)
$295.00 K(+6.1%)
Dec 2020
$278.00 K(+33.7%)
$75.00 K(+4.2%)
$278.00 K(+6.1%)
Sep 2020
-
$72.00 K(+5.9%)
$262.00 K(+6.9%)
Jun 2020
-
$68.00 K(+7.9%)
$245.00 K(+8.4%)
Mar 2020
-
$63.00 K(+6.8%)
$226.00 K(+8.7%)
Dec 2019
$208.00 K(+35.9%)
$59.00 K(+7.3%)
$208.00 K(+39.6%)
Sep 2019
-
$55.00 K(+12.2%)
$149.00 K(+58.5%)
Jun 2019
-
$49.00 K(+8.9%)
$94.00 K(+108.9%)
Mar 2019
-
$45.00 K
$45.00 K
Dec 2018
$153.00 K
-
-

FAQ

  • What is Keros Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Keros Therapeutics?
  • What is Keros Therapeutics annual D&A year-on-year change?
  • What is Keros Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Keros Therapeutics?
  • What is Keros Therapeutics quarterly D&A year-on-year change?
  • What is Keros Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Keros Therapeutics?
  • What is Keros Therapeutics TTM D&A year-on-year change?

What is Keros Therapeutics annual depreciation & amortization?

The current annual D&A of KROS is $1.23 M

What is the all time high annual D&A for Keros Therapeutics?

Keros Therapeutics all-time high annual depreciation & amortization is $1.23 M

What is Keros Therapeutics annual D&A year-on-year change?

Over the past year, KROS annual depreciation & amortization has changed by +$414.00 K (+50.80%)

What is Keros Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of KROS is $332.00 K

What is the all time high quarterly D&A for Keros Therapeutics?

Keros Therapeutics all-time high quarterly depreciation & amortization is $332.00 K

What is Keros Therapeutics quarterly D&A year-on-year change?

Over the past year, KROS quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is Keros Therapeutics TTM depreciation & amortization?

The current TTM D&A of KROS is $1.23 M

What is the all time high TTM D&A for Keros Therapeutics?

Keros Therapeutics all-time high TTM depreciation & amortization is $1.23 M

What is Keros Therapeutics TTM D&A year-on-year change?

Over the past year, KROS TTM depreciation & amortization has changed by $0.00 (0.00%)